Orchestra BioMed Holdings, Inc. (OBIO) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 116 transactions totaling $2.5M, demonstrating a bullish sentiment with $2.0M in net insider flow. The most recent transaction on Feb 5, 2026 involved a transaction of 676 shares valued at $2.5K.
No significant insider buying has been recorded for OBIO in the recent period.
No significant insider selling has been recorded for OBIO in the recent period.
Based on recent SEC filings, insider sentiment for OBIO is bullish with an Insider Alignment Score of 91/100 and a net flow of $2.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Orchestra BioMed Holdings, Inc. (OBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading OBIO stock, having executed 116 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 1 transactions totaling $1.9M.
Get notified when executives and directors at OBIO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Cleary Chris | Executive | Payment | 676 | $3.71 | $2.5K | |
| Jan 28, 2026 | Sherman Darren | Executive | Award | 34,974 | $N/A | $0 | |
| Jan 2, 2026 | Sherman Darren | Executive | Payment | 5,588 | $4.31 | $24.1K | |
| Jan 2, 2026 | Aiello Joshua | Principal Accounting Officer | Payment | 241 | $4.31 | $1.0K | |
| Jan 2, 2026 | Lawrence Taylor Andrew | Chief Financial Officer | Payment | 3,452 | $4.31 | $14.9K | C-Suite |
| Dec 10, 2025 | P. Hochman David | Executive | Payment | 3,283 | $4.67 | $15.3K | |
| Dec 10, 2025 | P. Hochman David | Executive | Payment | 40,355 | $4.67 | $188.5K | |
| Dec 10, 2025 | Lawrence Taylor Andrew | Executive | Payment | 8,670 | $4.67 | $40.5K | |
| Nov 25, 2025 | Sherman Darren | Executive | Payment | 40,340 | $5.35 | $215.8K | |
| Nov 25, 2025 | Lawrence Taylor Andrew | Executive | Payment | 3,071 | $5.35 | $16.4K | |
| Nov 14, 2025 | P. Hochman David | Executive | Purchase | 5,000 | $4.07 | $20.4K | |
| Nov 13, 2025 | P. Hochman David | Executive | Payment | 3,283 | $4.18 | $13.7K | |
| Nov 13, 2025 | P. Hochman David | Executive | Payment | 3,283 | $4.18 | $13.7K | |
| Sep 19, 2025 | Aryeh Jason | Executive | Purchase | 1,000 | $2.45 | $2.5K | |
| Sep 17, 2025 | P. Hochman David | Executive | Payment | 3,283 | $2.46 | $8.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 19 | $2.2M | 67.7% |
Payment(F) | 17 | $806.2K | 24.5% |
Sale(S) | 8 | $225.6K | 6.8% |
Award(A) | 55 | $24.9K | 0.8% |
Exercise(M) | 15 | $5.6K | 0.2% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Orchestra BioMed Holdings, Inc. are accumulating shares at an accelerated pace. With 21 insiders making 116 transactions totaling $2.2M in purchases versus $225.6K in sales, the net buying activity of $2.0M signals strong executive confidence. Life Sciences Master Fund Ltd Perceptive (Executive) leads the buying activity with $1.9M in transactions across all time.